Gallacher Capital Management’s Merck MRK Stock Holding History

Gallacher Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,534	Closed	-$252K	–	327
2024 Q4	$252K	Sell	2,534 -852	-25%	-$87.8K	0.13%	225
2024 Q3	$385K	Buy	+3,386	New	+$402K	0.18%	149
2024 Q1	–	Sell	-2,365	Closed	-$258K	–	295
2023 Q4	$258K	Buy	+2,365	New	+$245K	0.14%	195
2023 Q3	–	Sell	-2,146	Closed	-$248K	–	260
2023 Q2	$248K	Buy	+2,146	New	+$244K	0.14%	202

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gallacher Capital Management's MRK Position: Q1 2025 in Review

Gallacher Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 2,534 shares — an estimated $252K sold.

Gallacher Capital Management first reported a position in MRK in Q2 2023 and held it in 4 quarters. The position peaked at $385K in Q3 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Gallacher Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Gallacher Capital Management sold 2,534 Merck shares in Q1 2025, an estimated $252K.
Gallacher Capital Management first reported a position in Merck in Q2 2023 and held it in 4 quarters.
Gallacher Capital Management's Merck position peaked at $385K in Q3 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Gallacher Capital Management's 13F filing for Q1 2025, filed 5 May 2025.